LDLR and atherosclerosis: Proprotein convertase subtilisin/kexin type 9 (PCSK9), an enzyme involved in low-density lipoprotein receptor degradation has been shown to not only promote early atherosclerosis but also being ubiquitously present in the body including neural tissue [17].